Last reviewed · How we verify

hyoscine-N-butyl bromide(HBB)

Sisli Hamidiye Etfal Training and Research Hospital · FDA-approved active Small molecule

hyoscine-N-butyl bromide(HBB) is a Anticholinergic antispasmodic Small molecule drug developed by Sisli Hamidiye Etfal Training and Research Hospital. It is currently FDA-approved for Abdominal pain and cramping associated with irritable bowel syndrome, Gastrointestinal spasms, Urinary tract spasms and dysuria. Also known as: Molit amp..

Hyoscine-N-butyl bromide is an anticholinergic agent that blocks muscarinic acetylcholine receptors to reduce smooth muscle spasms and secretions.

Hyoscine-N-butyl bromide is an anticholinergic agent that blocks muscarinic acetylcholine receptors to reduce smooth muscle spasms and secretions. Used for Abdominal pain and cramping associated with irritable bowel syndrome, Gastrointestinal spasms, Urinary tract spasms and dysuria.

At a glance

Generic namehyoscine-N-butyl bromide(HBB)
Also known asMolit amp.
SponsorSisli Hamidiye Etfal Training and Research Hospital
Drug classAnticholinergic antispasmodic
TargetMuscarinic acetylcholine receptors (M1-M5)
ModalitySmall molecule
Therapeutic areaGastroenterology
PhaseFDA-approved

Mechanism of action

HBB competitively antagonizes muscarinic cholinergic receptors on smooth muscle in the gastrointestinal and urinary tracts, reducing involuntary contractions and spasms. As a quaternary ammonium compound, it is poorly absorbed systemically and acts primarily at peripheral sites, minimizing central nervous system effects. This results in antispasmodic and antisecretory effects useful in treating visceral pain and cramping.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about hyoscine-N-butyl bromide(HBB)

What is hyoscine-N-butyl bromide(HBB)?

hyoscine-N-butyl bromide(HBB) is a Anticholinergic antispasmodic drug developed by Sisli Hamidiye Etfal Training and Research Hospital, indicated for Abdominal pain and cramping associated with irritable bowel syndrome, Gastrointestinal spasms, Urinary tract spasms and dysuria.

How does hyoscine-N-butyl bromide(HBB) work?

Hyoscine-N-butyl bromide is an anticholinergic agent that blocks muscarinic acetylcholine receptors to reduce smooth muscle spasms and secretions.

What is hyoscine-N-butyl bromide(HBB) used for?

hyoscine-N-butyl bromide(HBB) is indicated for Abdominal pain and cramping associated with irritable bowel syndrome, Gastrointestinal spasms, Urinary tract spasms and dysuria, Biliary colic.

Who makes hyoscine-N-butyl bromide(HBB)?

hyoscine-N-butyl bromide(HBB) is developed and marketed by Sisli Hamidiye Etfal Training and Research Hospital (see full Sisli Hamidiye Etfal Training and Research Hospital pipeline at /company/sisli-hamidiye-etfal-training-and-research-hospital).

Is hyoscine-N-butyl bromide(HBB) also known as anything else?

hyoscine-N-butyl bromide(HBB) is also known as Molit amp..

What drug class is hyoscine-N-butyl bromide(HBB) in?

hyoscine-N-butyl bromide(HBB) belongs to the Anticholinergic antispasmodic class. See all Anticholinergic antispasmodic drugs at /class/anticholinergic-antispasmodic.

What development phase is hyoscine-N-butyl bromide(HBB) in?

hyoscine-N-butyl bromide(HBB) is FDA-approved (marketed).

What are the side effects of hyoscine-N-butyl bromide(HBB)?

Common side effects of hyoscine-N-butyl bromide(HBB) include Dry mouth, Constipation, Blurred vision, Urinary retention, Tachycardia.

What does hyoscine-N-butyl bromide(HBB) target?

hyoscine-N-butyl bromide(HBB) targets Muscarinic acetylcholine receptors (M1-M5) and is a Anticholinergic antispasmodic.

Related